In vitro Antiplasmodial Activity of Methanol Stem Extract of Costus afer Ker Gawl. (Costaceae) and its Residual Aqueous Fraction Against Some Drug-sensitive and Drug-resistant Plasmodium falciparum Strains doi.org/10.26538/tjnpr/v3i5.3

Article Sidebar

PDF DOI
Published: Mar 8, 2023
Keywords:
Plasmodium falciparum, In vitro, Costus afer, Antiplasmodial

Main Article Content

AbdulFatai A. Jimoh
Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, Kaduna State University, Kaduna. Nigeria.
Bilkisu B. Maiha
Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria. Nigeria.
Ben A. Chindo
Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, Kaduna State University, Kaduna. Nigeria.
Janet I. Ejiofor
Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria. Nigeria.
Joseph O. Ehinmidu
Department of Pharmaceutics and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria. Nigeria.
David A. Atang
Department of Pharmaceutics and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria. Nigeria.
Jonathan Y. Azi
Department of Pharmaceutics and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria. Nigeria.

Abstract

Malaria remains a major public health problem in many countries in the tropical and sub-tropical regions of the world. The resistance of malaria parasites to commonly used antimalarial drugs including artemisinin-combination therapies in some Southeast Asian  countries poses a great challenge to malaria control programmes. The aim of this study was to investigate the in vitro  antiplasmodial activity of the methanol stem extract of Costus afer and its residual aqueous fraction against chloroquine-sensitive, chloroquine-resistant and artemether-resistant Plasmodium falciparum strains. Methanol stem extract of the plant was obtained by maceration of the powdered stem in 70% v/v methanol and residual aqueous fraction was obtained by successive solvent fractionation with  dichloromethane, ethylacetate and finally n-butanol. In-vitro antiplasmodial activity was assessed using the candle jar method with some slight modifications. The methanol stem extract of Costus afer and its residual aqueous fraction produced significant and dose-dependent inhibitions of schizont growth in all the three Plasmodium strains with IC50 values of 8.86 and 10.51, 11.27 and 15.05, and 10.30 and 11.23 µg/mL against chloroquine-sensitive, chloroquine-resistant and artemether-resistant strains, respectively. Chloroquine phosphate was the most potent against chloroquine-sensitive strain (IC50 = 0.81 µg/mL) and Quinine sulphate was the most active  against both chloroquine-resistant and artemether-resistant strains (IC50 values of 8.6 and 1.45 µg/mL, respectively). This study hasshown that Costus afer stem extracts possess in-vitro antiplasmodial activity and it may be a good remedy for both chloroquine-sensitive, chloroquine-resistant and artemether-resistant falciparum malaria or a source of lead compounds for new antimalarial drugs.

Downloads

Download data is not yet available.

Article Details

How to Cite
Jimoh, A. A., Maiha, B. B., Chindo, B. A., Ejiofor, J. I., Ehinmidu, J. O., Atang, D. A., & Azi, J. Y. (2023). In vitro Antiplasmodial Activity of Methanol Stem Extract of Costus afer Ker Gawl. (Costaceae) and its Residual Aqueous Fraction Against Some Drug-sensitive and Drug-resistant Plasmodium falciparum Strains: doi.org/10.26538/tjnpr/v3i5.3. Tropical Journal of Natural Product Research (TJNPR), 3(5), 162-169. https://tjnpr.org/index.php/home/article/view/1699
Issue
Vol. 3 No. 5 (2019): Tropical Journal of Natural Product Research
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite

Jimoh, A. A., Maiha, B. B., Chindo, B. A., Ejiofor, J. I., Ehinmidu, J. O., Atang, D. A., & Azi, J. Y. (2023). In vitro Antiplasmodial Activity of Methanol Stem Extract of Costus afer Ker Gawl. (Costaceae) and its Residual Aqueous Fraction Against Some Drug-sensitive and Drug-resistant Plasmodium falciparum Strains: doi.org/10.26538/tjnpr/v3i5.3. Tropical Journal of Natural Product Research (TJNPR), 3(5), 162-169. https://tjnpr.org/index.php/home/article/view/1699

References

Centre for Disease control and Prevention (CDC). Centre for Disease Control andprevention/CDC malaria : Malaria fact sheet, 2004.

World Health Organization (WHO). WHO Malaria Factsheet No 94.2013. WHO Press, Geneva, Switzerland.

Kantele A and Jokiranta TS. Review of cases with the emerging fifth human malaria parasite,Plasmodium knowlesi. Clin Infect Dis. 2011; 52(11):1356-1362.

World Health Organization (WHO). World malaria report 2018. Geneva, Switzerland.

World Health Organization (WHO).World malaria report (2017a). Geneva, Switzerland.

Kouani SF, Khan SN, Krohn K, Ngadjui BT, Kapche DGWF, Yapna DB, Zareem S, Moustafa AMY, Choudhari MI. J Nat Prod. 2006; 69:229-233.

Nayyar GML, Breman JG, Newton PN, Henrrington J. Poor quality antimalarial drugs in Southeast Asia and sub-Saharan Africa. Lancet Infect Dis. 2012; 12(6):488-496.

Cohen J, Nussenzweig V, Nussenzweig R, Vekemans J, Leah A. From the circumsporozoite protein to the RTS, S/AS candidate vaccine. Hum Vac Immunother. 2010; 6:90-96.

Agnandji ST, Lell B, Soulanoudjingar SS, Fernandes JF, Abossolo BB, Conzelmann C, Methogo BGNO, Doucka Y, Flamen A, Mordmuller B, Issifou S, Kremsner PG, Sacarlai J, Aide P, Lanaspa M, Aponte JJ, Nhamuave A, Quelhas D, Bassat Q,Mandjate S, Macete E, Alonso P, Abdulla S, Salim N, Juma O, Shomari M, Shubis K, Machera F, Hamad AS, Minja R, Mpina M, Mtoro A, Skyes A, Ahmed S, Urassa AM, Ali AM, Nwangoka G, Tanner M, Tinto, H, D’Alessandro U, Sorgho H, Valea I, Tahita MC, Kabore W, Queadraogo S, Sandrine Y, Guiguemde RT, Quedraogo JB, Hamel MJ, Kariuki S, Odero C, Oneko M, Otieno K, Awino M, Omoto J, Williamson J, Muturi-Kioi V, Lasersan KF, Slutsker L, Otieno W, Otieno L, Nekoye O, Gondi S, Otieno A, Ogutu B, Wasuna R, Owira V, Jones D, Onyango AA, Njuguna P, Chilengi R, Akoo P, Kerubo C, Gitaka J, Maingi C, Langi T, Olotu A, Tsofa B, Benjon P, Peshu N, Marsh K, Owusu-Agyei S, Asante KP, Osei-Kwakye K, Boahen O, Ayamba S, Kayan K, Owusu-Ofori R, Dosoo D, Asante I, Adjei G, Kwara E, Chandramohan D, Greenwood B, Lusingu J, Gesase S, Malabeja A, Abdul O, Kilavo H, Mahende C, Liheluka E, Lemnge E, Lemnge M, Theander T, Drakeley C, Ansong D, Agbenyega T, Adjei S, Boateng HO, Rettig T, Bawa J, Sylverken J, Sambian D, Agyekum A, Owusu L, Martinson F, Hoffman I, Mvalo T, Kamthunzi P, Nkomo R, Msika A, Jumbe A, Chome N, Nyakuipa D, Chintedza J, Ballou WR, Bruls M, Cohen J, Guerra Y, Jongert E, Lapierre D, Leach A, Lievens M, Ofori-Anyinam O, Vekemans J, Carter T, Leboulleux D, Loucq C, Radford A, Savarese B, Schellenberg D, Sillman MS, Vansadia P. First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children. N Engl J Med. 2011;365:1863-1875.

Schwartz L, Brown GV, Genton B, Morthy VS. A review of malaria vaccine clinical projects based on WHO rainbow table. Malaria J 2012; 11:11.

Wilby KJ, Lau TTY, Gilchrist SE, Ensom MMH. Mosquirix (RTS,S) : a Novel vaccine for the prevention of Plasmodium falciparum malaria. Ann Pharmacotherapy 2012; 46:384–393. 10.1345/aph.1Q634.

Agandi ST, Lell B, Ferenandes JF. Abossolo BP., Kabwende AL, Adegnika AA, Mordmuller B, Iddifou D, Kremsner PG et al. Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination : A Phase 3 randomized controlled trial in children and young infants at 11 African sites. The RTS, S Clinical Trials Partnership. PLOS Med. 2014; 11(7):e1001685.

McCarthy JS, Marjason J, Elliot S, Fahey P, Bang G, Malkin E, Tierney E, Aked-Hurditch H, Adda C, Cross N, Richard JS, Fowkes FJ, Bovie MJ, Long C, Druilhe P.,Beeson JG., Anders RF. A Phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSPP2 formulated with MotanideH ISA 720. PLoS ONE 2011; 6:e24413.

Herrera S, Corradin G, Arevalo-Herrera M. An update on the search for a Plasmodium vivax vaccine. Trends Parasitol. 2007; 23:122-128.

Arevalo-Herrera M, Chitnis C, Herrera S. Current status of Plasmodium vivax vaccine. Hum Vac Immunother 2010; 6:124-132.

Gregory JA, Li F, Tomosada LM, Cox CJ, Topol AB, Vinetz JM, Mayfield S. Algae-produced pfs25 elicits antibodies that inhibit malaria transmission. PLOS ONE 2012; 7:e37179.

Gelb MH. Drug discovery for malaria : A very challenging and timely endeavour. ScienceDirect : Curr Opin Chem Biol. 2007; 11:440-445.

Horeau L and Dasilva EJ. Medicinal plants: a re-emerging health aid. Electro J Biotech. 1999; 2:56-69.

Addae-Mensah I, Fakorede F, Holtel A, Nwaka S. Traditional medicines as a mechanism for driving research innovation in Africa. Malar J. 2011; 10(1):S9-10.

Guantai E and Chibale K. How can natural products serve as a viable source of lead compounds for the development of new/novel anti-malarials? Malar J. 2011; 10(1):S2-10.

Cruz LR, Spangenberg T, Lacerda MVG, Wells TNC. Malaria in South America: A drug discovery perspective. Malar J. 2013; 12:168-10.1186/1475-28 75-12-168.

Willcox ML and Bodeker G. Traditional herbal medicines for malaria. BMJ. 2004; 329(7475):1156–1159.

Baird JK, Caneta-Miguel E, Masba S, Bustus DG, Abrenica JA, Layawen AV, Caluluf JM, Leksana B, Wignall FS. Survey of resistance to chloroquine of falciparum and vivax malaria in Palawan, The Phillipines. Trans Roy Soc Trop Med Hyg. 1996; 90:413-414.

Bruce-Chwatt LJ. Qinghaosu: a new antimalarial. BMJ (Clinical Research Ed), 1982; 284:767-768.

Klayman DL. Qinghaosu (artemisinin) : an antimalarial drug from China. Sci. 1985; 228:1049-1055.

Muhammad S and Amusa NA. The important food crops and medicinal plants of North-Western Nigeria. Res J Agric Biol Sci. 2005; 1(3):254-260.

Gessler MC, Nkunya, MHH, Mwasumbi LB, Heinrich M, Tanner M. Screening Tanzanian medicinal plants for antimalarial activity. J Ethnopharmacol. 1994; 66(1):66-77.

Cimanga K. The biologically active constituents of two African medicinal plants: Cryptolepis sanguinolenta (Lindl). Schlecter (periplocaceae) and Morinda momrindoides (Baker). Ann Trop Med Parasitol. 1997; 95(1):47-57.

Rahman NN, Furuta T, Kojima S, Tabane K, Ali-Mohd M. In-vitro study of medicinal plants : Piper sarmentosum, Andrographis paniculata and Tinospora crispa. J Ehnopharmacol. 1999; 64:249-254.

Agbedahunsi JM, Elujoba AA, Makinde JM, Oduda AM. Anti-malarial activity of Khaya grandifoliola stem-bark. Pharm Biol. 1998; 36:8-12.

Titanji VPK, Dennis Z, Ngemenya MN. The antimalarial potential of medicinal plants used for the treatment of malaria in Cameroonian folk medicine. Afr J Trad Compl Altern Med. 2002; 5(3):302-321.

Chinnaperumal K. Antimalarial activity of medicinal plants used in the villages of Dharmapuri regions of south India. J Ethnopharmacol. 2012; 141(3):14:796-802.

Majekodunmi SO, Adegoke OA, Odeku OA. Formulation of the extract of the stem bark of Alstonia boonei as tablet dosage form. Trop J Pharm Res. 2008; 7:987–994.

Ajibesin KK, Ekpo BA, Bala DN, Essien EE, Adesanya SA. Ethnobotanical survey of Akwa Ibom State of Nigeria. J Ethnopharmacol. 2008; 115:387–408.

Okoko TC. Stem extracts from the monocot Costus afer ameliorates paracetamol induced tissue injury in rats. Int J Pure Appl Sci. 2009; 3:21-25.

World Health Organization (WHO). Global malaria control and elimination : A report of technical review. Jan 2008. Geneva, Switzerland.

Adebayo JO and Krettli AU. Potential antimalarials from Nigerian plants: A review. J Ethnopharmacol. 2011; 133(2):289–302.

Edeoga HO and Okoli BE. Chromosome numbers of Costus lucanusianus (Costaceae) in Nigeria. Folia Geobotanica 2000; 35:315-318.

Burkill HM. The useful plants of West Tropical Africa( 2nd Edition. Volume 1), Families A-D. Royal Botanical Gardens, Kew, Richmond, United Kingdom, 1985. 960 p.

Anaga AO, Njoku CJ, Ekejiuba ES, Esiaka MN, Asuzu IU. Investigations of the methanolic leaf extract of Costus afer Ker Gawl. for pharmacological activities in vitro and in vivo. Phytomed. 2004; 11(2-3):242-248.

Soladoye MO and Oyesika OO. Textbook of Medicinal Plants from Nigeria, University of Lagos Press, Nigeria. 2008. 628 p.

Lin RC, Hanquet B, Lacaille-Dubois MA. Aferoside A. A steroidal saponin from Costus afer. J Pharmacogn Phytochem. 1996; 43:665-668.

Aweke GH. Costus afer Ker Gawl. In : Schmelzer GH, Gurib-Fakim A. Prota 11 (1): medicinal plants/plantes medicinales 1. Wageningen, Netherlands : PROTA ; 2007. Available : http : //database.prota.org/search.html (Accessed 23rd August, 2016). 44. Taiwo AO and Bolanle AA. The leaf essential oil of Costus afer Ker Gawl from Nigeria. Flavour Fragr J. 2003; 18:309-311.

Guzman AI and Guerrero RO. Effecto hypoglycemi ante de Costus specious (Zingiberaceae), en rats. Vitea Revista de la Faculdad de Quimica Farmaceutica 2002; 9:51-57.

Odoh UE, Ezugwu CO, Ajali U. Antitussive properties of the methanol leaf extract of Costus afer. J Trop Med Plants 2010; 11(2):149-152.

Dacie JV and Lewis SM. Practical Haematology. (4th ed.) Blackwell Publishers, U.S.A. 1968. 65-68 p.

Trager W and Jensen JB. Human malaria parasites in continuous culture. Sci. 1976; 193:673-675.

Ziegler HL, Staerk D, Christensen J, Hviid L, Hagerstrand H, Jaroszewski JW. In vitro Plasmodium falciparum sensitivity assay. Antimicrob Agents Chemother, 2002; 42(6):1441-1446.

Moll K, Ljungstrom I, Perlmann H, Scherf A, Wahlgren M. Methods in Malaria Research. University Boulevard : Manassas. 2008.

Bickii J, Tchouya GRF, Tchouankeu JC, Tsamo E. Antimalarial activity in crude extracts of some Cameroonian medicinal plants. Afr J Trad Compl Altern Med, 2007; 4(1):107-111.

Arnida A, Wahyono W, Mustofa M, Asmahsudarti R. In vitro antiplasmodial activity of ethanol extracts of Borneo medicinal plants (Hydroleaspinosa, Ampelocissurubiginosa, Uraria crinite, Angiopterisevecta). Int J Pharm Pharm Sci. 2015; 7(5):72-75.

Zahari A, Ablat A, Sivasothy Y, Mohamad J, Choudhary MI, Awang K. In vitro antiplasmodial and antioxidant activities of bisbenzylisoquinoline alkaloids from Alseodaphne corneri Kosterm. Asian Pac J Trop Med. 2016; 03(008):1- 5.

Nosten F and White NJ. Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg. 2007; 77(suppl 6):181-192.

do Nascimento MS, Pina NPV, da Silva ASB, Gomes LFS, de Vasconcellos F, Brandao GC, do Nascimento MFA, de Olivera AB and Barbosa WLR. .In vitro antiplasmodial activity and identification using tandem LC-MS of alkaloids from Aspidosperma excelsum, a plant used to treat malaria in Amazonia. J Ethnopharmacol 2019; 228:99-109.

Kassa M, Mohana R, Hunde A. Antimalarial activity of Bersama Abyssinica against Plasmodium falciparum. Ethiop Pharm J. 1996; 14:16-21.

Katuura E, Waako P, Tabuti JRS. Bukenya-Ziraba R, Ogwal-Okeng J. Antiplasmodial activity of extracts of selected medicinal plants used by local communities in western Uganda for treatment of malaria. Afr J Ecol. 2007; 45(S3):94-98.